Kempner Capital Management Has Increased By $2.51 Million Its Merck & Co. (MRK) Stake; 10 Analysts Bullish LyondellBasell Industries N.V. (LYB)

Merck & Co., Inc. (NYSE:MRK) Logo

Kempner Capital Management Inc increased Merck & Co. Inc. (MRK) stake by 212.86% reported in 2017Q4 SEC filing. Kempner Capital Management Inc acquired 44,827 shares as Merck & Co. Inc. (MRK)’s stock declined 4.63%. The Kempner Capital Management Inc holds 65,886 shares with $3.71M value, up from 21,059 last quarter. Merck & Co. Inc. now has $152.98B valuation. The stock increased 0.96% or $0.54 during the last trading session, reaching $56.74. About 11.94 million shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since April 13, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Among 25 analysts covering LyondellBasell (NYSE:LYB), 10 have Buy rating, 3 Sell and 12 Hold. Therefore 40% are positive. LyondellBasell had 76 analyst reports since September 1, 2015 according to SRatingsIntel. The stock of LyondellBasell Industries N.V. (NYSE:LYB) earned “Hold” rating by Jefferies on Tuesday, October 10. The rating was maintained by RBC Capital Markets on Thursday, January 25 with “Hold”. RBC Capital Markets maintained the stock with “Hold” rating in Tuesday, October 17 report. On Friday, February 10 the stock rating was downgraded by Susquehanna to “Neutral”. The stock has “Buy” rating by Citigroup on Tuesday, February 6. The stock of LyondellBasell Industries N.V. (NYSE:LYB) earned “Buy” rating by Alembic on Monday, August 7. As per Thursday, December 29, the company rating was maintained by Cowen & Co. The firm has “Buy” rating by S&P Research given on Tuesday, October 27. The company was maintained on Tuesday, September 13 by Deutsche Bank. RBC Capital Markets maintained LyondellBasell Industries N.V. (NYSE:LYB) rating on Tuesday, October 31. RBC Capital Markets has “Hold” rating and $110.0 target. See LyondellBasell Industries N.V. (NYSE:LYB) latest ratings:

27/03/2018 Broker: BMO Capital Markets Rating: Buy New Target: $111.0000 Initiate
18/03/2018 Broker: Susquehanna Rating: Hold New Target: $121.0 Maintain
16/02/2018 Broker: Morgan Stanley Rating: Buy New Target: $130.0 Maintain
12/02/2018 Broker: Alembic Rating: Buy Maintain
06/02/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $120 New Target: $125 Maintain
05/02/2018 Broker: SunTrust Rating: Hold New Target: $105.0 Maintain
05/02/2018 Broker: Morgan Stanley Rating: Buy New Target: $130.0 Maintain
05/02/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $115 New Target: $125 Maintain
31/01/2018 Broker: Cowen & Co Rating: Hold New Target: $125.0 Maintain
25/01/2018 Broker: RBC Capital Markets Rating: Hold New Target: $119.0 Maintain

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 19 have Buy rating, 0 Sell and 5 Hold. Therefore 79% are positive. Merck & Co. Inc. has $7400 highest and $50 lowest target. $65.22’s average target is 14.95% above currents $56.74 stock price. Merck & Co. Inc. had 83 analyst reports since August 13, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, August 4 by BMO Capital Markets. The firm has “Buy” rating by Citigroup given on Monday, October 30. The stock has “Outperform” rating by BNP Paribas on Tuesday, August 18. The firm has “Hold” rating by SunTrust given on Monday, October 30. The company was maintained on Monday, July 17 by Jefferies. The firm earned “Sell” rating on Friday, October 20 by Jefferies. The stock of Merck & Co., Inc. (NYSE:MRK) has “Buy” rating given on Wednesday, November 15 by Bernstein. The rating was downgraded by Barclays Capital to “Equal-Weight” on Monday, October 30. The firm earned “Buy” rating on Monday, October 30 by UBS. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) on Friday, March 23 with “Hold” rating.

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.12, from 1.06 in 2017Q3. It turned negative, as 94 investors sold MRK shares while 631 reduced holdings. 123 funds opened positions while 558 raised stakes. 1.93 billion shares or 1.34% less from 1.96 billion shares in 2017Q3 were reported. Princeton Port Strategies Llc reported 1.58% in Merck & Co., Inc. (NYSE:MRK). Ironwood Invest Mgmt Ltd owns 5,459 shares for 0.22% of their portfolio. Moreover, Bbva Compass Fincl Bank Incorporated has 0.29% invested in Merck & Co., Inc. (NYSE:MRK) for 79,914 shares. 262,936 are owned by New Mexico Educational Retirement Board. Hudock Capital Gp Limited Liability holds 38,540 shares. Drw Secs Ltd Liability Com reported 38,328 shares. Schnieders Capital Mgmt Ltd Limited Liability Company, California-based fund reported 16,618 shares. Grisanti Capital Mngmt Ltd Limited Liability Company invested 2.74% in Merck & Co., Inc. (NYSE:MRK). Burney invested in 0.11% or 33,790 shares. Camarda Limited Liability holds 1.07% or 15,904 shares. 10,810 were accumulated by Train Babcock Advisors Llc. Clearbridge Investments Ltd holds 0.68% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 13.15 million shares. Focused Wealth Mngmt has invested 0.13% in Merck & Co., Inc. (NYSE:MRK). Ccm Investment Advisers Ltd Llc holds 0.15% in Merck & Co., Inc. (NYSE:MRK) or 14,117 shares. Silvercrest Asset Mngmt Grp Limited Liability Corp reported 469,669 shares.

The stock increased 1.46% or $1.49 during the last trading session, reaching $103.7. About 4.21 million shares traded or 68.83% up from the average. LyondellBasell Industries N.V. (NYSE:LYB) has risen 17.51% since April 13, 2017 and is uptrending. It has outperformed by 5.96% the S&P500.

LyondellBasell Industries N.V. operates as a maker of chemicals and polymers, refiner of crude oil, producer of gasoline blending components, and developer and licensor of technologies for production of polymers worldwide. The company has market cap of $40.92 billion. The firm operates in five divisions: Olefins and Polyolefins—Americas; Olefins and Polyolefins—Europe, Asia, International; Intermediates and Derivatives; Refining; and Technology. It has a 8.48 P/E ratio. It produces and markets olefins, including ethylene, propylene, and butadiene; polyethylene products, which consist of high density polyethylene, low density polyethylene, and linear low density polyethylene; polyolefins, such as polyethylene and polypropylene ; and PP homopolymers, copolymers, and compounds.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.07, from 0.84 in 2017Q3. It increased, as 51 investors sold LyondellBasell Industries N.V. shares while 271 reduced holdings. 88 funds opened positions while 206 raised stakes. 288.04 million shares or 0.22% more from 287.42 million shares in 2017Q3 were reported. Virtus Investment Advisers Incorporated owns 192,765 shares or 1.11% of their US portfolio. Piedmont Invest Limited Liability Company stated it has 0.34% of its portfolio in LyondellBasell Industries N.V. (NYSE:LYB). Delphi Mgmt Ma invested in 15,721 shares. Quantum Mngmt holds 0.2% of its portfolio in LyondellBasell Industries N.V. (NYSE:LYB) for 7,440 shares. Zacks Management reported 0.8% in LyondellBasell Industries N.V. (NYSE:LYB). Calamos Advisors Limited Liability Company holds 59,158 shares. Adams Diversified Equity Fund reported 93,700 shares. The Sweden-based Livforsakringsbolaget Skandia Omsesidigt has invested 0.15% in LyondellBasell Industries N.V. (NYSE:LYB). Adell Harriman & Carpenter reported 0.83% of its portfolio in LyondellBasell Industries N.V. (NYSE:LYB). Daiwa Secs Grp has invested 0.01% in LyondellBasell Industries N.V. (NYSE:LYB). Sei Invests holds 0.07% or 177,156 shares in its portfolio. Hourglass Ltd Liability Com invested in 43,460 shares or 1.09% of the stock. 162,353 are held by Ahl Prtn Llp. Earnest Prns Limited Liability Corporation accumulated 161 shares. Sandy Spring Retail Bank holds 0.07% of its portfolio in LyondellBasell Industries N.V. (NYSE:LYB) for 7,002 shares.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart